Providing enabling technologies to support you from Discovery to Delivery.
Esco Pharma was one of the exhibitors at the High Potent Medicines Conference last June 6-7, 2017 in Berlin, Germany. The conference focused on strategies and challenges in the high potent medicines industry.
Esco Pharma exhibited at the INTERPHEX 2017, the event for pharmaceutical and biotech professionals held last March 21-23, 2017 at Javits Center, NY, USA. The conference featured state-of-the-art solutions a manufacturer needs in developing and producing quality drug products.
CPhI-India and P-MEC were recently held last November 21 - 23, 2016 at two venues - 1. Bombay Convention & Exhibition Centre, Goregaon, Mumbai and 2. MMRDA Grounds, BKC, Mumbai.
Esco Healthcare, a division of Esco Group of Companies, participated at the recently culminated 16th International Society for Pharmaceutical Engineering (ISPE) Congress - Singapore Affiliate at the Suntec Singapore International Convention and Exhibition Centre last August 25 - 27, 2016.
Esco participated in the recently concluded prestigious conference, the American Society of Health-System Pharmacists (ASHP) Summer Meetings and Exhibitions 2016, held on June 11-15 at the Baltimore Convention Center, Baltimore, Maryland, USA.
Esco Group of Companies, a global life sciences tools provider active in laboratory, medical and pharmaceutical equipment, took part for the 1st time in the annual Philippine Pharmacists Association (PPhA) National Convention last May 25 - 28, 2016 at the Waterfront Hotel in Cebu City, Philippines.
VacciXcell, a subsidiary of Esco Group of companies, completes day 1 of the European Vaccine Congress. Of great interest is our latest CelCradle Single-Use Bioreactor that drew large responses from the international delegates.
On Sept 28-30, at Pharma Expo in Las Vegas, Esco Pharma showcased its latest platform isolators, including the Aseptic Containment Isolator with integrated hydrogen peroxide bio-decontamination system, inflatable seals, and safe change filter housings.